Author

Ankan Roy

Indian Council of Medical Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Samir Kumar PatraiD· 2 shared Bhagyashree PradhaniD· 1 shared Jagdish Mishra· 1 shared Niharika Mahto· 1 shared Niharika NiharikaiD· 1 shared Piyasa Nandi· 1 shared Prahallad Mishra· 1 shared Pujarini DashiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Samir Kumar PatraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

AKNA drives neural stem cell fate transition through differential localization and coordinating the modulation of chromatin from H3K27me3 to H3K27ac

Soumen Manna, R. Kirtana, Tirthankar Baral, Jagdish Mishra, Piyasa Nandi, Subhajit Chakraborty, Niharika Mahto, Ankan Roy, Prahallad Mishra, Bhagyashree Pradhan, Pujarini Dash, Samir Kumar Patra

The paper shows AKNA regulates neural stem cell fate by modulating chromatin states through interactions with KDM6B and signaling pathways.

bioRxiv · Sep 15, 2025 · PreprintMolecular Biology

Screening and identification of gene expression in large cohorts of clinical lung cancer samples unveils the major involvement of EZH2 and SOX2

Niharika Niharika, Ankan Roy, Ratan Sadhukhan, Samir Kumar Patra

The paper identifies EZH2 and SOX2 as key genes in LUAD through differential expression analysis and pathway enrichment, suggesting EZH2 as a potential therapeutic target.

bioRxiv · Sep 17, 2024 · PreprintGenetics